Mirabaud Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Sell
4,675
-7,944
-63% -$930K 0.5% 47
2026
Q1
$1.49M Buy
12,619
+851
+7% +$98.2K 1.23% 19
2025
Q4
$1.02M Sell
11,768
-1,602
-12% -$150K 0.47% 40
2025
Q3
$1.05M Hold
13,370
0.51% 36
2025
Q2
$1.06M Buy
13,370
+3,602
+37% +$286K 0.49% 38
2025
Q1
$872K Sell
9,768
-5,979
-38% -$558K 0.46% 41
2024
Q4
$1.55M Buy
15,747
+3,719
+31% +$383K 0.72% 33
2024
Q3
$1.37M Sell
12,028
-17,696
-60% -$2.1M 0.56% 41
2024
Q2
$3.68M Buy
29,724
+10,637
+56% +$1.37M 1.69% 24
2024
Q1
$2.52M Sell
19,087
-4,531
-19% -$558K 1.02% 30
2023
Q4
$2.57M Buy
+23,618
New +$2.45M 1.1% 29

Other funds holding MRK

Mirabaud Asset Management's MRK Position: Q2 2026 in Review

Mirabaud Asset Management reduced its Merck (MRK) stake by 63% in Q2 2026, selling an estimated $930K and leaving 4,675 shares worth $605K. The position accounts for 0.5% of the portfolio, ranked #47.

Mirabaud Asset Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.68M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mirabaud Asset Management held 4,675 shares of Merck worth $605K as of Q2 2026.
  • Mirabaud Asset Management sold 7,944 Merck shares in Q2 2026, an estimated $930K.
  • Merck made up 0.5% of Mirabaud Asset Management's portfolio in Q2 2026, its #47 holding.
  • Mirabaud Asset Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Mirabaud Asset Management's Merck position peaked at $3.68M in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mirabaud Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.